• Publications
  • Influence
Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
OBJECTIVE To identify features of antinuclear antibody (ANA)-HEp-2 test results that discriminate ANA-positive healthy individuals and patients with autoimmune rheumatic diseases (ARDs). METHODS WeExpand
  • 214
  • 12
Vitamin D deficiency in patients with active systemic lupus erythematosus
SummaryWe investigated the effects of disease activity on bone metabolism in 36 patients with systemic lupus erythematosus (SLE). Changes in bone remodeling were not explained by corticosteroid use.Expand
  • 168
  • 12
Brachial endothelial function is impaired in patients with systemic lupus erythematosus.
OBJECTIVE To verify if endothelial function is impaired in pre-menopausal women with systemic lupus erythematosus (SLE) and whether endothelial dysfunction is related to disease duration, cumulativeExpand
  • 192
  • 10
Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus.
OBJECTIVE To determine if supervised cardiovascular training improves exercise tolerance, aerobic capacity, depression, functional capacity, and quality of life in patients with systemic lupusExpand
  • 89
  • 5
Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
OBJECTIVE To evaluate the capacity of methotrexate (MTX) to control mild activity of systemic lupus erythematosus (SLE), and to evaluate the capacity of MTX to reduce steroid requirement, as well asExpand
  • 147
  • 4
Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients
This study aimed to evaluate the association between nailfold capillary abnormalities and the presence of Raynaud's phenomenon (RP), anti-U1-RNP, and anti-cardiolipin (aCL) antibodies in SLEExpand
  • 84
  • 4
Consenso brasileiro para o tratamento do lúpus eritematoso sistêmico (LES)
Objetivo: Elaborar recomendacao baseada na melhor evidencia cientifica para o tratamento das diversas manifestacoes do lupus eritematoso sistemico. Metodos: Oito reumatologistas que trabalham emExpand
  • 22
  • 4
Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide.
  • E. Atra, E. Sato
  • Medicine
  • Clinical and experimental rheumatology
  • 1 September 1993
Twenty three patients with SLE and cutaneous lesions not responsive to chloroquine, photoprotectors and corticosteroid in doses < 0.5 mg/kg/day were treated with thalidomide 300 mg/day. ThreeExpand
  • 100
  • 3
Antiplatelet therapy for the prevention of arterial ischemic events in takayasu arteritis.
BACKGROUND Vessel wall inflammation, atherosclerosis and hypercoagulability may be responsible for ischemic events in Takayasu arteritis (TA). No study has evaluated the effect of antiplateletExpand
  • 76
  • 3
  • PDF